Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion
Preprint in bioRxiv (July 2023)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
FYN: emerging biological roles and potential therapeutic targets in cancer
Article in Journal of Translational Medicine (February 2023)
Protein cysteine palmitoylation in immunity and inflammation
Article in The FEBS Journal (February 2021)